Pablo Tebas
University of Pennsylvania · Hospital of the University of Pennsylvania CRS · Penn Therapeutics CRS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
26
all conditions, ClinicalTrials.gov
NIH grants tied to them
6
3 more share only the name and are not shown
Trial papers
87
PubMed author-name match
Trials
Studies that name Pablo Tebas as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:03 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05293249 · dMAbs for Prevention of COVID-19Pablo Tebas · completed · Healthy Volunteers · principal investigator
- Ph1NCT03831503 · A Study of INO-A002 in Healthy Dengue Virus-naive AdultsUniversity of Pennsylvania · completed · Healthy Volunteers · principal investigator
- Ph4NCT03761953 · Oritavancin for Staphylococcus Aureus Infections in Opioid UsersUniversity of Pennsylvania · withdrawn · Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis · principal investigator
- Ph2NCT03739996 · Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1National Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph1NCT03705169 · Pharmacokinetics and Safety of SAR441236National Institute of Allergy and Infectious Diseases (NIAID) · terminated · HIV-1-infection · study chair
- Ph1NCT03617198 · CD4 CAR+ ZFN-modified T Cells in HIV TherapyUniversity of Pennsylvania · active not recruiting · Hiv · principal investigator
- Ph1NCT03588715 · Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)Luis Montaner · unknown · HIV, HIV/AIDS, HIV-1 Infection · study chair
- Early Ph1NCT03020524 · Autologous CD4 T-Cells in HIV (C34-CXCR4)University of Pennsylvania · completed · Hiv · principal investigator
- Ph1NCT02463227 · Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment InterruptionNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph1NCT02154360 · Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected SubjectsUniversity of Pennsylvania · completed · HIV Infection · principal investigator
- Ph1NCT01300988 · Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg DoseUniversity of Pennsylvania · completed · HIV Infection · principal investigator
- Ph4NCT01262846 · Improving Immunogenicity of Influenza Vaccine in HIV Infected IndividualsUniversity of Pennsylvania · completed · HIV Infection · principal investigator
- Ph4NCT01111162 · H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected PatientsUniversity of Pennsylvania · completed · HIV Infections · principal investigator
- Ph1NCT01082692 · Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult ParticipantsInovio Pharmaceuticals · completed · HIV-1 Infection, HIV Infections · principal investigator
- Ph4NCT00976040 · Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal MeningitisBotswana-UPenn Partnership · completed · Cryptococcal Meningitis, HIV Infections · principal investigator
- Ph1NCT00842634 · Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIVUniversity of Pennsylvania · completed · HIV, HIV Infections · principal investigator
- Ph1NCT00775424 · PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV InfectionUniversity of Pennsylvania · completed · HIV Infection · principal investigator
- Ph2NCT00594880 · Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 InfectionThe Wistar Institute · completed · HIV Infections · principal investigator
- Ph2NCT00528593 · Epoetin Alfa for HIV-Associated Neuropathy TrialWashington University School of Medicine · withdrawn · HIV Infections, Neuropathy · principal investigator
- Ph1NCT00428519 · Effects of Treatment With Aprepitant (Emend®) in HIV Infected IndividualsUniversity of Pennsylvania · completed · HIV Infections · principal investigator
- Ph2NCT00352911 · Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected SubjectsVGX Pharmaceuticals, LLC · completed · HIV Infections · principal investigator
- Ph1NCT00295477 · Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIVUniversity of Pennsylvania · completed · HIV · principal investigator
- Ph2NCT00255177 · Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected PatientsVGX Pharmaceuticals, LLC · completed · Hepatitis C Virus Infection · principal investigator
- N/ANCT00028314 · Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV PatientsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections, Lipodystrophy, Wasting Disease · study chair
- Ph2NCT00000850 · The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV TherapyNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- Ph2NCT00001132 · Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug CombinationNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- University of Pennsylvania HIV Clinical Trials UnitUM1AI069534 · NIAID · UNIVERSITY OF PENNSYLVANIA · fiscal years 2014 to 2026 · $2,830,682 awarded in 2026Same name and institution; not confirmed by an ID
- Developmental CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · fiscal years 2008 to 2023 · $815,816 awarded in 2023Same name and institution; not confirmed by an ID
- A PHASE I STUDY OF C34-CXCR4 MODIFIED CD4 T CELLS IN HIV-1 INFECTED INDIVIDUALSU19AI117950 · NIAID · UNIVERSITY OF PENNSYLVANIA · fiscal years 2015 to 2019 · $556,468 awarded in 2019Same name and institution; not confirmed by an ID
- Human Studies of NK-1R anatogonists in HIV-1 (project 4)P01MH076388 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · fiscal years 2005 to 2008 · $325,641 awarded in 2008Same name and institution; not confirmed by an ID
- AIDS CLINICAL TRIALS UNITU01AI032783 · NIAID · UNIVERSITY OF PENNSYLVANIA · fiscal years 2003 to 2007 · $725,484 awarded in 2007Same name and institution; not confirmed by an ID
- Mitochondria And Metabolic Complications Of HIVR21AI063995 · NIAID · UNIVERSITY OF PENNSYLVANIA · fiscal years 2005 to 2006 · $164,907 awarded in 2006Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- First-in-human study of two anti-SARS CoV-2 antibodies in health volunteersUM1AI126620 · NIAID · WISTAR INSTITUTE · PI Luis J Montaner, James L. Riley · fiscal years 2016 to 2021Named on NCT03588715
- Project 2U01MH090325 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI Steven Daniel Douglas · fiscal years 2009 to 2013Named on NCT01300988, NCT00428519
- Antiviral activity of Peg-IFN alpha in chronic HIV-1U01AI065279 · NIAID · WISTAR INSTITUTE · PI Luis J Montaner · fiscal years 2005 to 2009Named on NCT00594880
- NEUROLOGIC AIDS RESEARCH CONSORTIUMU01NS032228 · NINDS · WASHINGTON UNIVERSITY · PI DAVID B CLIFFORD · fiscal years 2003 to 2008Named on NCT00528593
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:03 UTC. The ranking covers the 200 most relevant of 87 PubMed records, and a shared surname and initials can bring in a namesake. All 87 on PubMed
- Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.N Engl J Med · 20141,041 citationsRCR 27.4
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.N Engl J Med · 2016426 citationsRCR 13.5
- 416 citationsRCR 13.7
- Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.N Engl J Med · 2015379 citationsRCR 14.1
- 342 citationsRCR 15.3
- Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.N Engl J Med · 1998273 citationsRCR 6.7
- Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.N Engl J Med · 2021252 citationsRCR 15.3
- Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.J Infect Dis · 2013176 citationsRCR 4.4
- 154 citationsRCR 4.1
- 123 citationsRCR 3.1